
NT5E - Wikipedia
NT5E (CD73) is a surface enzyme which is expressed on multiple cells. This enzyme mediates the gradual hydrolysis of the autocrine and paracrine danger signals of ATP and ADP to anti-inflammatory adenosine.
CD73: an emerging checkpoint for cancer immunotherapy - PMC
CD73 is a novel immune checkpoint associated with adenosine metabolism that promotes tumor progression by suppressing antitumor immune response and promoting angiogenesis.
CD73: a new immune checkpoint for leukemia treatment - PMC
CD73 shows varied tissue expression, predominantly in the colon, kidneys, brain, liver, heart, lungs, spleen, lymph nodes, and bone marrow. In the vascular system, CD73 primarily associates with vascular and lymphatic endothelia, playing a role in regulating leukocyte transport (19).
The Clinical Significance of CD73 in Cancer - PMC
The initial results suggest that inhibiting CD73 could be an effective option to augment anti-cancer immunotherapeutic strategies. This review provides an overview of the rationale behind the CD73 inhibition in different treatment combinations and the role of CD73 as a prognostic marker.
Development of CD73 Inhibitors in Tumor Immunotherapy and …
4 天之前 · CD73 is a member of the membrane-bound enucleotidase family, which catalyzes the extracellular hydrolysis of adenosine monophosphate (AMP) to produce anti-inflammatory and immunosuppressive adenosine. As a novel checkpoint protein, CD73 is overexpressed in the immune system of various tumors, where adenosine is abundantly enriched. A large number …
Targeting CD73 to augment cancer immunotherapy - PubMed
CD73 (ecto-5'-nucleotidase) is a novel immunoinhibitory protein that plays a key role for tumor growth and metastasis. Its main function is to convert extracellular ATP to immunosuppressive adenosine in concert with CD39 in normal tissues to limit excessive immune response.
CD39/CD73/A2AR pathway and cancer immunotherapy
2023年3月2日 · The sequential conversion of extracellular ATP into adenosine by two important cell-surface ectonucleosidases CD39 and CD73 play critical roles in reshaping an immunosuppressive TME.
CD73 Molecule Inhibitor Upregulates miR16 Expression in …
2 天之前 · The function of CD73 (Cluster of Differentiation 73), an enzyme involved in the formation of adenosine (ADO), in the development of glioblastomas has been demonstrated. Indeed, ADO helps tumor angiogenesis by stimulating endothelial cell migration, proliferation, and tube formation. However, the details of the molecular mechanisms are not yet fully …
Increased primary breast tumor expression of CD73 is ... - Nature
2025年3月19日 · Article Open access Published: 19 March 2025 Increased primary breast tumor expression of CD73 is associated with development of bone metastases and is a potential biomarker for adjuvant ...
CD73 Inhibitor: Novel Approaches to Immune Response
6 天之前 · Explore how CD73 inhibitors regulate immune responses by targeting adenosine production, with insights into inhibitor types and efficacy assessment methods.